1558.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 11:08):

Stats
Dzisiejszy wolumen	3.60M
Średni wolumen	2.19M
Kapitalizacja rynkowa	11.14B
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.114 ( 2020-09-29 )
Next Dividend	HKD0 ( N/A )
P/E	5.19
ATR14	HKD0.0140 (0.11%)

Wolumen Korelacja

Długi: -0.15 (neutral)

Krótki: -0.64 (weak negative)

Signal:(41.519) Neutral

YiChang HEC ChangJiang Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

YiChang HEC ChangJiang Korelacja - Waluta/Towar

0.26
( neutral )

0.63
( weak )

0.00
( neutral )

-0.59
( weak negative )

0.54
( weak )

0.70
( moderate )

YiChang HEC ChangJiang Finanse

Annual	2023
Przychody:	HKD6.29B
Zysk brutto:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2023
Przychody:	HKD6.29B
Zysk brutto:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2022
Przychody:	HKD3.74B
Zysk brutto:	HKD2.85B (76.00 %)
EPS:	HKD0.0871

FY	2021
Przychody:	HKD913.79M
Zysk brutto:	HKD483.70M (52.93 %)
EPS:	HKD-0.667

Financial Reports:

No articles found.

YiChang HEC ChangJiang Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

YiChang HEC ChangJiang Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.39%) | Divividend Growth Potential Score: 4.12 - Potential for dividend initiation, but uncertain (17.56%)

Information

First Dividend	HKD0.0885	2016-06-08
Last Dividend	HKD0.114	2020-09-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.08	--
Avg. Dividend % Per Year	0.00%	--
Score	3.09	--
Div. Sustainability Score	9.24
Div.Growth Potential Score	4.12
Div. Directional Score	6.68	--

Next Divdend (Est)
(2024-07-24)

HKD0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.09

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9987.HK	Ex Dividend Knight	2023-08-25	Quarterly	0.00%
2192.HK	Ex Dividend Junior	2023-11-07	Annually	0.00%
1193.HK	Ex Dividend Knight	2023-05-30	Semi-Annually	0.00%
0257.HK	Ex Dividend Junior	2023-09-25	Semi-Annually	0.00%
3933.HK	Ex Dividend Junior	2023-09-14	Sporadic	0.00%
1766.HK	Ex Dividend Junior	2023-06-21	Annually	0.00%
0808.HK	Ex Dividend Junior	2023-08-31	Semi-Annually	0.00%
2356.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
1319.HK	Ex Dividend Knight	2023-08-02	Semi-Annually	0.00%
0382.HK	Ex Dividend Knight	2023-05-10	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.317	1.500	3.67	5.50	[0 - 0.5]
returnOnAssetsTTM	0.156	1.200	4.79	5.75	[0 - 0.3]
returnOnEquityTTM	0.268	1.500	8.13	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.397	0.800	8.01	6.41	[1 - 3]
quickRatioTTM	0.869	0.800	9.59	7.67	[0.8 - 2.5]
cashRatioTTM	0.387	1.500	8.96	10.00	[0.2 - 2]
debtRatioTTM	0.205	-1.500	6.59	-9.88	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.505	2.00	9.25	10.00	[0 - 20]
debtEquityRatioTTM	0.329	-1.500	8.68	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.792	1.000	0.132	0.132	[0.2 - 0.8]
operatingProfitMarginTTM	0.443	1.000	3.13	3.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.641	1.000	7.55	7.55	[0.2 - 2]
assetTurnoverTTM	0.494	0.800	-0.0406	-0.0325	[0.5 - 2]
Total Score				9.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.16	1.000	9.58	0	[1 - 100]
returnOnEquityTTM	0.268	2.50	8.80	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.505	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0783	1.500	-2.81	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.266	1.000	5.85	0	[0.1 - 0.5]
Total Score				4.12

YiChang HEC ChangJiang

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.